TCHH

gene
On this page

Summary

TCHH (trichohyalin, HGNC:11791) is a protein-coding gene on chromosome 1q21.3, encoding Trichohyalin (Q07283). Intermediate filament-associated protein that associates in regular arrays with keratin intermediate filaments (KIF) of the inner root sheath cells of the hair follicle and the granular layer of the epidermis.

The protein encoded by this gene forms crosslinked complexes with itself and keratin intermediate filaments to provide mechanical strength to the hair follicle inner root sheath. The encoded protein also is important for structural integrity of the filiform papillae of the tongue. Defects in this gene are a cause of uncombable hair syndrome.

Source: NCBI Gene 7062 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): uncombable hair syndrome 3 (Limited, GenCC)
  • GWAS associations: 11
  • Clinical variants (ClinVar): 473 total — 3 likely-pathogenic
  • Phenotypes (HPO): 6
  • MANE Select transcript: NM_007113

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:11791
Approved symbolTCHH
Nametrichohyalin
Location1q21.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000159450
Ensembl biotypeprotein_coding
OMIM190370
Entrez7062

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000614923

RefSeq mRNA: 1 — MANE Select: NM_007113 NM_007113

CCDS: CCDS41396

Canonical transcript exons

ENST00000614923 — 3 exons

ExonStartEnd
ENSE00001447994152106317152113078
ENSE00003744354152113943152114111
ENSE00003745138152115391152115444

Expression profiles

Bgee: expression breadth ubiquitous, 101 present calls, max score 97.35.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2648 / max 314.3512, expressed in 11 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
145340.264811

Top tissues by expression

248 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
upper arm skinUBERON:000426397.35gold quality
tongue squamous epitheliumUBERON:000691989.29gold quality
skin of hipUBERON:000155488.57gold quality
placentaUBERON:000198780.98gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099178.39silver quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047376.89gold quality
sural nerveUBERON:001548869.09gold quality
nippleUBERON:000203068.44gold quality
body of tongueUBERON:001187665.70gold quality
hair follicleUBERON:000207365.50silver quality
tongueUBERON:000172363.36gold quality
zone of skinUBERON:000001461.93gold quality
upper leg skinUBERON:000426261.39gold quality
spleenUBERON:000210661.05gold quality
skin of abdomenUBERON:000141659.68gold quality
skin of legUBERON:000151158.08gold quality
endometrium epitheliumUBERON:000481157.87gold quality
cortical plateUBERON:000534356.49gold quality
endothelial cellCL:000011555.94gold quality
palpebral conjunctivaUBERON:000181254.90silver quality
prefrontal cortexUBERON:000045154.58gold quality
parotid glandUBERON:000183153.81silver quality
cervix squamous epitheliumUBERON:000692252.66silver quality
superior surface of tongueUBERON:000737151.27gold quality
Brodmann (1909) area 10UBERON:001354150.81gold quality
Brodmann (1909) area 46UBERON:000648350.54gold quality
frontal poleUBERON:000279550.41gold quality
quadriceps femorisUBERON:000137750.38gold quality
middle frontal gyrusUBERON:000270250.30gold quality
paraflocculusUBERON:000535150.18gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.86

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

73 targeting TCHH, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-126-5P100.0072.713180
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-4682100.0068.891258
HSA-MIR-188-3P100.0068.761240
HSA-MIR-3646100.0073.565283
HSA-MIR-428299.9975.366408
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-1213699.9872.815713
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-477599.9875.006394
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-211099.9666.681930
HSA-MIR-365899.9673.874379
HSA-MIR-3682-5P99.9367.971163
HSA-MIR-130599.9171.433443
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-990299.8969.152250
HSA-MIR-427199.8868.322244
HSA-MIR-576-5P99.8470.462582
HSA-MIR-132399.8369.892471
HSA-MIR-6875-3P99.8270.262983
HSA-MIR-548AJ-5P99.7871.123085
HSA-MIR-548F-5P99.7871.023093
HSA-MIR-548G-5P99.7871.123085
HSA-MIR-548X-5P99.7871.123085
HSA-MIR-3617-5P99.7569.411968
HSA-MIR-64199.7569.351975

Literature-anchored findings (GeneRIF, showing 9)

  • BMP-4 signalling activates AHF transcription in hair follicles. (PMID:18643848)
  • In human keratinocytes, we found BMP-4 facilitates trichohyalin (THH) transcription, and lamin C plays a key role in the posttranslational stabilization of THH. (PMID:18643848)
  • Common variants in the TCHH gene are associated with straight hair in Europeans. (PMID:19896111)
  • Data suggest that an immune response to trichohyalin and K16 may have a role in the pathogenesis of the enigmatic disorder. (PMID:20722389)
  • The difference between the twoinduced pluripotent stem cell(IPSC) clones in TCHH methylation did not have an obvious effect on its expression in 3D human epidermal equivalent, suggesting that differentiation and tissue formation may mitigate variations in the iPSC methylome. (PMID:27460132)
  • To evaluate the relative contribution of these variants, we performed a second genome-wide scan in 709 samples from the Uyghur, an admixed population with both eastern and western Eurasian ancestries. In Uyghurs, both EDAR (rs3827760: P = 1.92 x 10(-12)) and TCHH (rs11803731: P = 1.46 x 10(-3)) are associated with hair straightness, but EDAR (OR 0.415) has a greater effect than TCHH (OR 0.575). (PMID:27487801)
  • The two enzymes PADI3 and TGM3, responsible for posttranslational protein modifications, and their target structural protein TCHH are all involved in hair shaft formation. (PMID:27866708)
  • Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer. (PMID:34110642)
  • Identification of MKI67, TPR , and TCHH Mutations as Prognostic Biomarkers for Patients With Defective Mismatch Repair Colon Cancer Stage II/III. (PMID:37643197)

Cross-species orthologs

1 orthologs

OrganismSymbolGene ID
mus_musculusTchhENSMUSG00000052415

Protein

Protein identifiers

TrichohyalinQ07283 (reviewed: Q07283)

All UniProt accessions (1): Q07283

UniProt curated annotations — full annotation on UniProt →

Function. Intermediate filament-associated protein that associates in regular arrays with keratin intermediate filaments (KIF) of the inner root sheath cells of the hair follicle and the granular layer of the epidermis. It later becomes cross-linked to KIF by isodipeptide bonds. It may serve as scaffold protein, together with involucrin, in the organization of the cell envelope or even anchor the cell envelope to the KIF network. It may be involved in its own calcium-dependent postsynthetic processing during terminal differentiation.

Subunit / interactions. Monomer.

Tissue specificity. Found in the hard keratinizing tissues such as the inner root sheath (IRS) of hair follicles and medulla, and in the filiform papillae of dorsal tongue epithelium.

Post-translational modifications. Substrate of transglutaminase. Some 200 arginines are probably converted to citrullines by peptidylarginine deimidase.

Disease relevance. Uncombable hair syndrome 3 (UHS3) [MIM:617252] A form of uncombable hair syndrome, a condition characterized by scalp hair that is impossible to comb due to the haphazard arrangement of the hair bundles. A characteristic morphologic feature is a triangular to reniform to heart shape on cross-sections, and a groove, canal or flattening along the entire length of the hair. Most individuals are affected early in childhood and the hair takes on a spun-glass appearance with the hair becoming dry, curly, glossy, lighter in color, and progressively uncombable. The hair growth rate can range from slow to normal, and the condition improves with age. The disease is caused by variants affecting the gene represented in this entry.

Domain organisation. Consists of nine domains. Domain 1 contains two EF-hand calcium-binding domains. Domains 2-4, 6, and 8 are almost entirely alpha-helical, configured as a series of peptide repeats of varying regularity, and are thought to form a single-stranded alpha-helical rod stabilized by ionic interactions. Domain 6 is the most regular and may bind KIF directly by ionic interactions. Domains 5 and 7 are less well organized and may induce folds in the molecule. Domain 9 contains the C-terminus, conserved among different species.

Similarity. Belongs to the S100-fused protein family.

RefSeq proteins (1): NP_009044* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001751S100/CaBP7/8-like_CSConserved_site
IPR002048EF_hand_domDomain
IPR011992EF-hand-dom_pairHomologous_superfamily
IPR013787S100_Ca-bd_subDomain
IPR018247EF_Hand_1_Ca_BSBinding_site
IPR033200TCHHFamily
IPR034325S-100_domDomain

Pfam: PF01023

UniProt features (93 total): repeat 23, region of interest 22, compositionally biased region 17, sequence conflict 15, sequence variant 7, binding site 6, domain 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q07283-F167.960.00

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (6): 32; 62; 64; 66; 68; 73

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-6809371Formation of the cornified envelope

MSigDB gene sets: 0 (showing top):

GO Biological Process (2): keratinization (GO:0031424), intermediate filament organization (GO:0045109)

GO Molecular Function (3): calcium ion binding (GO:0005509), transition metal ion binding (GO:0046914), metal ion binding (GO:0046872)

GO Cellular Component (3): cornified envelope (GO:0001533), cytosol (GO:0005829), cytoskeleton (GO:0005856)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Keratinization1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
metal ion binding2
keratinocyte differentiation1
multicellular organismal process1
intermediate filament cytoskeleton organization1
supramolecular fiber organization1
cation binding1
plasma membrane1
cytoplasm1
cellular anatomical structure1
intracellular membraneless organelle1

Protein interactions and networks

STRING

1571 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TCHHLORICRINP23490977
TCHHIVLP07476977
TCHHPADI3Q9ULW8880
TCHHS100A10P08206846
TCHHS100A6P06703748
TCHHSPRR1AP35321724
TCHHSPRR3Q9UBC9679
TCHHTTC3P78477657
TCHHFLGP20930645
TCHHFLG2Q5D862639
TCHHSPRR1BP22528622
TCHHRPTNQ6XPR3604
TCHHS100A1P23297584
TCHHPLECQ15149556
TCHHC4BPAP04003556

IntAct

16 interactions, top by confidence:

ABTypeScore
CCND1CDK2psi-mi:“MI:0914”(association)0.880
OAZ3AZIN1psi-mi:“MI:0914”(association)0.800
CCND1CDK1psi-mi:“MI:0914”(association)0.640
NSMAFDUSP14psi-mi:“MI:0914”(association)0.530
CCDC127CETN3psi-mi:“MI:0914”(association)0.530
TCHHLMNApsi-mi:“MI:0915”(physical association)0.400
EZRMACROD2psi-mi:“MI:0914”(association)0.350
TBC1D14psi-mi:“MI:0914”(association)0.350
BPIFA1HLA-DPA1psi-mi:“MI:0914”(association)0.350
NSMCE1TCHHpsi-mi:“MI:0914”(association)0.350
HS1BP3MPOpsi-mi:“MI:0914”(association)0.350
CUL4BCAND2psi-mi:“MI:0914”(association)0.350
EFHD1TCHHpsi-mi:“MI:0915”(physical association)0.000

BioGRID (25): TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Proximity Label-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS), TCHH (Affinity Capture-MS)

ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A0A1B0GV03, A6NEF3, A6NEM1, A6NI86, A8MZA4, B4DH59, D3YVF0, F6QRE9, H0YKK7, H0YM25, P0C6Y7, P0C7A2, P0DX00, P0DX01, P0DX02, P14590, P21263, P22793, P24587, P24710, P48997, P48998, Q07283, Q0II65, Q0P6D6, Q13342, Q3BBV2, Q4R9C9, Q5W0A0, Q6AXX0, Q6NSX1, Q6P5H2, Q6P902, Q86T75, Q8CHD8, Q8N2N9, Q8N660, Q8N7Z2

Diamond homologs: A6QP92, P20930, P37709, P97347, Q07283, Q2VIS4, Q5D862, Q5QJ38, Q6XPR3, Q9D3P1, Q9UBG3, A7K6Y8, A7K6Y9, O77691, O77791, P02632, P02633, P02634, P02638, P02639, P04163, P04271, P04631, P05109, P05942, P05943, P05964, P06702, P06703, P07091, P08207, P10462, P14069, P22793, P23297, P24479, P24480, P25815, P26447, P27003

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 21 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
DNA damage response513.4×2e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

473 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic3
Uncertain significance419
Likely benign44
Benign5

Top pathogenic / likely-pathogenic (3)

Variant IDHGVSClassification
2504039NM_007113.4(TCHH):c.699del (p.Gln234fs)Likely pathogenic
374835NM_007113.4(TCHH):c.991C>T (p.Gln331Ter)Likely pathogenic
4056308NM_007113.4(TCHH):c.1153_1162del (p.Arg385fs)Likely pathogenic

SpliceAI

88 predictions. Top by Δscore:

VariantEffectΔscore
1:152113077:CT:Cacceptor_gain0.9900
1:152113937:TCTTA:Tdonor_loss0.9900
1:152113938:CTTAC:Cdonor_loss0.9900
1:152113939:TTACC:Tdonor_loss0.9900
1:152113940:TACC:Tdonor_loss0.9900
1:152113941:A:Tdonor_loss0.9900
1:152113941:AC:Adonor_gain0.9900
1:152113942:C:CTdonor_loss0.9900
1:152113942:CC:Cdonor_gain0.9900
1:152113079:C:CCacceptor_gain0.9800
1:152113941:A:ACdonor_gain0.9800
1:152113942:C:CCdonor_gain0.9800
1:152113081:A:Cacceptor_gain0.9700
1:152113963:C:Adonor_gain0.9700
1:152113075:GTCTC:Gacceptor_loss0.9600
1:152113076:TCT:Tacceptor_gain0.9600
1:152113077:CTC:Cacceptor_gain0.9600
1:152113078:TCTA:Tacceptor_loss0.9600
1:152113078:TCTAT:Tacceptor_gain0.9600
1:152113079:CTATA:Cacceptor_loss0.9600
1:152112974:CACTT:Cacceptor_gain0.9500
1:152113079:C:Gacceptor_gain0.9500
1:152113075:GTCT:Gacceptor_gain0.9400
1:152113074:GGTCT:Gacceptor_gain0.9200
1:152113935:GTTCT:Gdonor_loss0.8900
1:152113936:TTCTT:Tdonor_loss0.8900
1:152113087:A:Cacceptor_gain0.8700
1:152113081:A:ACacceptor_gain0.8500
1:152113090:G:Cacceptor_gain0.8500
1:152113087:A:ACacceptor_gain0.8300

AlphaMissense

12834 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:152113983:A:GL33P0.994
1:152113974:A:GL36P0.992
1:152112995:G:CF74L0.990
1:152112995:G:TF74L0.990
1:152112997:A:GF74L0.990
1:152113971:A:TL37H0.988
1:152114036:G:CF15L0.988
1:152114036:G:TF15L0.988
1:152114038:A:GF15L0.988
1:152112996:A:GF74S0.986
1:152113004:G:CF71L0.986
1:152113004:G:TF71L0.986
1:152113006:A:GF71L0.986
1:152113971:A:GL37P0.986
1:152112993:A:GL75P0.984
1:152112972:G:TA82D0.983
1:152113998:A:GL28S0.982
1:152112967:C:GA84P0.980
1:152113038:A:GL60P0.980
1:152111105:C:AW704C0.979
1:152111105:C:GW704C0.979
1:152112973:C:GA82P0.979
1:152107419:T:CY1933C0.978
1:152113958:A:CF41L0.978
1:152113958:A:TF41L0.978
1:152113959:A:GF41S0.978
1:152113960:A:GF41L0.978
1:152107416:A:GI1934T0.977
1:152107433:G:CS1928R0.976
1:152107433:G:TS1928R0.976

dbSNP variants (sampled 300 via entrez): RS1000292552 (1:152115936 T>C), RS1000444196 (1:152115658 G>A), RS1000732136 (1:152115216 C>T), RS1002899585 (1:152114485 C>T), RS1003646576 (1:152111312 C>T), RS1003808065 (1:152113145 CAT>C), RS1004540078 (1:152106404 G>C), RS1005490681 (1:152112803 C>A), RS1006249936 (1:152111038 C>T), RS1007032156 (1:152115057 C>T), RS1007457279 (1:152116502 G>C), RS1007470835 (1:152115535 C>T), RS1007776301 (1:152116875 A>G), RS1007926410 (1:152107221 A>T), RS1008249698 (1:152117026 A>C,G)

Disease associations

OMIM: gene MIM:190370 | disease phenotypes: MIM:617252

GenCC curated gene-disease

DiseaseClassificationInheritance
uncombable hair syndrome 3LimitedAutosomal recessive

Mondo (1): uncombable hair syndrome 3 (MONDO:0014990)

Orphanet (0):

HPO phenotypes

6 total (6 of 6 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0002212Curly hair
HP:0002235Pili canaliculi
HP:0002299Brittle hair
HP:0011463Childhood onset
HP:0030056Uncombable hair

GWAS associations

11 associations (top):

StudyTraitp-value
GCST000519_12Hair morphology3.000000e-31
GCST000706_1Common traits (Other)2.000000e-42
GCST003474_1Scalp hair shape3.000000e-12
GCST006661_183Male-pattern baldness1.000000e-10
GCST007563_33Allergic disease (asthma, hay fever or eczema)3.000000e-11
GCST007564_24Asthma or allergic disease (pleiotropy)5.000000e-12
GCST008916_82Asthma5.000000e-27
GCST008916_88Asthma1.000000e-25
GCST009718_16Eczema1.000000e-64
GCST009798_26Asthma2.000000e-21
GCST010605_1Parent of origin effect on receptive language ability (paternal)9.000000e-06

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0005038hair morphology
EFO:0005686receptive language perception
EFO:0005939parental genotype effect measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases expression, increases methylation2
Silicon Dioxideincreases expression2
Tetrachlorodibenzodioxindecreases expression, increases expression2
Tretinoinincreases expression2
bisphenol Fincreases expression1
sotorasibaffects cotreatment, increases expression1
propionaldehydeincreases expression1
sodium arsenateincreases abundance, decreases expression1
butyraldehydeincreases expression1
benzo(e)pyrenedecreases methylation1
aflatoxin B2decreases methylation1
pentanalincreases expression1
abrineincreases expression1
trametinibaffects cotreatment, increases expression1
NVP-BKM120affects cotreatment, increases expression1
Resveratrolaffects cotreatment, decreases expression1
Fulvestrantdecreases methylation1
Aldehydesincreases expression1
Arsenicdecreases expression, increases abundance1
Copperdecreases expression, affects cotreatment1
Methapyrilenedecreases methylation1
Tobacco Smoke Pollutiondecreases expression1
Valproic Aciddecreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.